Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) — Defensive Interval Ratio
Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) has a Defensive Interval Ratio of 0 days as of December 2024. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $1.37K/day. Check how resilient are Lakewood-Amedex Biotherapeutics Inc. Com's assets to evaluate the company's liquid asset resilience ratio.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Lakewood-Amedex Biotherapeutics Inc. Common Stock Defensive Interval Ratio (2023–2024)
This chart shows how Lakewood-Amedex Biotherapeutics Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2023 to 2024. As of December 2024, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See Lakewood-Amedex Biotherapeutics Inc. Com short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Defensive Interval Ratio for Lakewood-Amedex Biotherapeutics Inc. Common Stock (2023–2024)
The table below presents the year-by-year Defensive Interval Ratio for Lakewood-Amedex Biotherapeutics Inc. Common Stock from 2023 to 2024, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of Lakewood-Amedex Biotherapeutics Inc. Com.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 0 days | $0.00 | $1.37K/day | $- | $0.00 | ▼ -683 days |
| 2023 | 683 days | $3.86 Million | $5.65K/day | $- | $3.86 Million | — |